# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001513162-19-000221
Filing Date
2019-10-24
Accepted
2019-10-24 16:43:23
Documents
25
Period of Report
2019-10-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | form8k.htm | 8-K | 49004
2 | EXHIBIT 99.1 | exhibit99_1.htm | EX-99.1 | 5541
3 | GRAPHIC | slide1.jpg | GRAPHIC | 72516
4 | GRAPHIC | slide2.jpg | GRAPHIC | 244233
5 | GRAPHIC | slide3.jpg | GRAPHIC | 164548
6 | GRAPHIC | slide4.jpg | GRAPHIC | 219388
7 | GRAPHIC | slide5.jpg | GRAPHIC | 204085
8 | GRAPHIC | slide6.jpg | GRAPHIC | 187686
9 | GRAPHIC | slide7.jpg | GRAPHIC | 290287
10 | GRAPHIC | slide8.jpg | GRAPHIC | 136847
11 | GRAPHIC | slide9.jpg | GRAPHIC | 100994
12 | GRAPHIC | slide10.jpg | GRAPHIC | 191006
13 | GRAPHIC | slide11.jpg | GRAPHIC | 159883
14 | GRAPHIC | slide12.jpg | GRAPHIC | 158707
15 | GRAPHIC | slide13.jpg | GRAPHIC | 151706
16 | GRAPHIC | slide14.jpg | GRAPHIC | 215527
17 | GRAPHIC | slide15.jpg | GRAPHIC | 196356
18 | GRAPHIC | slide16.jpg | GRAPHIC | 148960
19 | GRAPHIC | slide17.jpg | GRAPHIC | 224979
20 | GRAPHIC | slide18.jpg | GRAPHIC | 142716
21 | GRAPHIC | slide19.jpg | GRAPHIC | 214357
22 | GRAPHIC | slide20.jpg | GRAPHIC | 168456
23 | GRAPHIC | slide21.jpg | GRAPHIC | 186615
24 | GRAPHIC | slide22.jpg | GRAPHIC | 279212
25 | GRAPHIC | slide23.jpg | GRAPHIC | 206599
| Complete submission text file | 0001513162-19-000221.txt |  | 5932463

Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

EIN.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-37492 | Film No.: 191166599
SIC: 8071 Services-Medical Laboratories